Warning: The NCBI web site requires JavaScript to function. more...
Systems biology-defined NF-kappaB regulons, interacting signal pathways and networks are implicated in the malignant phenotype of head and neck cancer cell lines differing in p53 status.
Yan B, Chen G, Saigal K, Yang X, Jensen ST, Van Waes C, Stoeckert CJ, Chen Z.
Genome Biol. 2008;9(3):R53. Epub 2008 Mar 11.
Related citations
A signal network involving coactivated NF-kappaB and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas.
Lee TL, Yeh J, Friedman J, Yan B, Yang X, Yeh NT, Van Waes C, Chen Z.
Int J Cancer. 2008 May 1;122(9):1987-98.
Genome-wide identification of novel expression signatures reveal distinct patterns and prevalence of binding motifs for p53, nuclear factor-kappaB and other signal transcription factors in head and neck squamous cell carcinoma.
Yan B, Yang X, Lee TL, Friedman J, Tang J, Van Waes C, Chen Z.
Genome Biol. 2007;8(5):R78.
A novel nuclear factor-kappaB gene signature is differentially expressed in head and neck squamous cell carcinomas in association with TP53 status.
Lee TL, Yang XP, Yan B, Friedman J, Duggal P, Bagain L, Dong G, Yeh NT, Wang J, Zhou J, Elkahloun A, Van Waes C, Chen Z.
Clin Cancer Res. 2007 Oct 1;13(19):5680-91.
Attenuated transforming growth factor beta signaling promotes nuclear factor-kappaB activation in head and neck cancer.
Cohen J, Chen Z, Lu SL, Yang XP, Arun P, Ehsanian R, Brown MS, Lu H, Yan B, Diallo O, Wang XJ, Van Waes C.
Cancer Res. 2009 Apr 15;69(8):3415-24. Epub 2009 Apr 7.
Bortezomib-induced apoptosis with limited clinical response is accompanied by inhibition of canonical but not alternative nuclear factor-{kappa}B subunits in head and neck cancer.
Allen C, Saigal K, Nottingham L, Arun P, Chen Z, Van Waes C.
Clin Cancer Res. 2008 Jul 1;14(13):4175-85.
Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma.
Jackson-Bernitsas DG, Ichikawa H, Takada Y, Myers JN, Lin XL, Darnay BG, Chaturvedi MM, Aggarwal BB.
Oncogene. 2007 Mar 1;26(10):1385-97. Epub 2006 Sep 4.
Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.
Duffey DC, Chen Z, Dong G, Ondrey FG, Wolf JS, Brown K, Siebenlist U, Van Waes C.
Cancer Res. 1999 Jul 15;59(14):3468-74.
Identification of direct genomic targets downstream of the nuclear factor-kappaB transcription factor mediating tumor necrosis factor signaling.
Tian B, Nowak DE, Jamaluddin M, Wang S, Brasier AR.
J Biol Chem. 2005 Apr 29;280(17):17435-48. Epub 2005 Feb 18.
Proenkephalin assists stress-activated apoptosis through transcriptional repression of NF-kappaB- and p53-regulated gene targets.
McTavish N, Copeland LA, Saville MK, Perkins ND, Spruce BA.
Cell Death Differ. 2007 Sep;14(9):1700-10. Epub 2007 Jun 29.
A TNF-induced gene expression program under oscillatory NF-kappaB control.
Tian B, Nowak DE, Brasier AR.
BMC Genomics. 2005 Sep 28;6:137.
Function of polo-like kinase 3 in NF-kappaB-mediated proapoptotic response.
Li Z, Niu J, Uwagawa T, Peng B, Chiao PJ.
J Biol Chem. 2005 Apr 29;280(17):16843-50. Epub 2005 Jan 25.
Nuclear NF-kappaB p65 phosphorylation at serine 276 by protein kinase A contributes to the malignant phenotype of head and neck cancer.
Arun P, Brown MS, Ehsanian R, Chen Z, Van Waes C.
Clin Cancer Res. 2009 Oct 1;15(19):5974-84. Epub 2009 Sep 29.
Comparison of gene expression between metastatic derivatives and their poorly metastatic parental cells implicates crucial tumor-environment interaction in metastasis of head and neck squamous cell carcinoma.
Chen Z, Zhang K, Zhang X, Yuan XH, Yuan Z, Jin L, Xiong M.
Clin Exp Metastasis. 2003;20(4):335-42.
Pathway-specific profiling identifies the NF-kappa B-dependent tumor necrosis factor alpha-regulated genes in epidermal keratinocytes.
Banno T, Gazel A, Blumenberg M.
J Biol Chem. 2005 May 13;280(19):18973-80. Epub 2005 Feb 18.
Protein kinase Cdelta activates RelA/p65 and nuclear factor-kappaB signaling in response to tumor necrosis factor-alpha.
Lu ZG, Liu H, Yamaguchi T, Miki Y, Yoshida K.
Cancer Res. 2009 Jul 15;69(14):5927-35. Epub 2009 Jun 23.
p53 gene expression and 2-methoxyestradiol treatment differentially induce nuclear factor kappa B activation in human lung cancer cells with different p53 phenotypes.
Rath PC, Mukhopadhyay T.
DNA Cell Biol. 2009 Dec;28(12):615-23.
Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma.
Loercher A, Lee TL, Ricker JL, Howard A, Geoghegen J, Chen Z, Sunwoo JB, Sitcheran R, Chuang EY, Mitchell JB, Baldwin AS Jr, Van Waes C.
Cancer Res. 2004 Sep 15;64(18):6511-23. Erratum in: Cancer Res. 2004 Nov 1;64(21):8130-2.
cDNA microarray and bioinformatic analysis of nuclear factor-kappaB related genes in squamous cell carcinoma.
Chen Z, Lee TL, Yang XP, Dong G, Loercher A, Van Waes C.
Methods Mol Biol. 2007;383:81-99.
Nuclear factor-kappaB pathway as a therapeutic target in head and neck squamous cell carcinoma: pharmaceutical and molecular validation in human cell lines using Velcade and siRNA/NF-kappaB.
Lun M, Zhang PL, Pellitteri PK, Law A, Kennedy TL, Brown RE.
Ann Clin Lab Sci. 2005 Summer;35(3):251-8.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on